Senate Finance committee chair Ron Wyden (D-OR) on Wednesday sent follow-up letters to Merck and Abbott after both companies failed to answer questions and comply with his investigation into how a 2017 tax law helped slash tax rates for large, US-based pharma companies thanks to shifting profits offshore.
Last April,...
